Press Releases

NEW YORK (November 6, 2017)—TB Alliance today announced the appointment of Dr. Ariel Pablos-Méndez to its board of directors. As

The World Health Organization’s (WHO) 2017 Global Tuberculosis Report, released today, showed a reduction in TB deaths in 2016 compared

GUADALAJARA (10 October, 2017) — TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have

NEW YORK (27 September, 2017)—TB Alliance commends the World Health Organization (WHO) for recognizing tuberculosis (TB) as a priority pathogen

The World Health Organization (WHO) has just prequalified a two-pills-in-one pediatric medicine that is critical for the continuation phase of

HAMBURG, July 10 2017 – TB Alliance joins a coalition of 35 worldwide health advocates as well as numerous individuals from research institutes,

On May 23, 2017, the World Health Assembly elected Dr. Tedros Adhanom Ghebreyesus as the next Director-General of the World Health Organization.

BRUSSELS, 11 MAY 2017 — Leaders from the governments of France and the Netherlands today urged funding for new treatment

NEW YORK and GENEVA, 24 March 2017 — On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP)

TB Alliance and the broader TB community urge that the World Health Organization (WHO) add Mycobacterium tuberculosis to the critical